Jan P. van Meerbeeck - Publications, H-index & Citations

Jan P. van Meerbeeck

university of antwerp

90H指数

704论文数

3.5W被引数

收录论文 167

发表时间

Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis 通过呼出气体分析鉴别良性与恶性孤立性肺结节

ERJ Open Research

IF4

2026-02-16

PREAI

Zwijsen, Kathleen; Wener, Reinier R. L.; Heirwegh, Ellen; van Meerbeeck, Jan P.; Schillebeeckx, Eline; Raskin, Jo; Marcq, Elly; Van Schil, Paul E.; Snoeckx, Annemiek; Janssens, Annelies; Lamote, Kevin

Staging of Lung Cancer: A Call for Developing Uniform and Universal Key Performance Indicators and Benchmarks to Elevate Clinical Standards 肺癌分期: 呼吁制定统一和通用的关键绩效指标和基准，以提高临床标准

Journal of Thoracic Oncology

IF20.8

2026-02-04

PREAI

Jan P. Van Meerbeeck; Jelle E. Bousema; Wen Wen; Paul E.Y. Van Schil

Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells 缺氧诱导胸膜间皮瘤细胞挥发性特征的变化

Biomedicine & Pharmacotherapy

IF7.5

2026-01-14

OAAI

Eline Janssens; Ellen Heirwegh; An Wouters; Lore Vandermeersch; Jan P. Van Meerbeeck; Christophe Walgraeve; Elly Marcq; Kevin Lamote

Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations

Lung Cancer

IF4.4

2026-01-03

PREAI

Kathleen Zwijsen; Ellen Heirwegh; Eline Schillebeeckx; Elly Marcq; Adrian Covaci; Ken Op de Beeck; Jan P. van Meerbeeck; Jo Raskin; Annelies Janssens; Annemiek Snoeckx; Kevin Lamote

Design and rationale of the ZORALCS study: An implementation study of lung cancer screening by low-dose computed tomography coupled to a smoking cessation randomized controlled trial in the Flemish region ZORALCS研究的方案设计与原理：一项在弗拉芒地区实施的、结合低剂量计算机断层扫描肺癌筛查与戒烟随机对照试验的实施研究

Journal of Medical Screening

IF2.3

2025-12-30

PREAI

Charlotte Theuns; Amber Gerris; Jan P van Meerbeeck; Guido Van Hal; Frele Stevens; Jan De Lepeleire; Jason Bouziotis; Lauren Michiels; Kaat Ramaeckers; Annemiek Snoeckx

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies 甲基化生物标志物可以区分胸膜间皮瘤与正常胸膜及其他胸膜病变。

Molecular Oncology

IF4.5

2025-11-14

OAAI

Janah Vandenhoeck; Nele De Meulenaere; Thomas Vanpoucke; Joe Ibrahim; Dieter Peeters; Suresh Krishan Yogeswaran; Wen Wen; Paul Van Schil; Jeroen M. H. Hendriks; Jo Raskin; Jan van Meerbeeck; Guy Van Camp; Ken Op de Beeck

Quality Performance Indicators for Lung Cancer Screening: Towards the Next Levels?肺癌筛查的质量绩效指标：迈向下一阶段？

Journal of Thoracic Oncology

IF20.8

2025-06-06

PREAI

Jan Van Meerbeeck; Guido Van Hal; Annemiek Snoeckx

Haptoglobin phenotype: A germline risk factor for malignant pleural mesothelioma? A case-control study 结合珠蛋白表型：恶性胸膜间皮瘤的生殖细胞风险因素？一项病例对照研究

CLINICA CHIMICA ACTA

IF2.9

2025-06-01

PREAI

Lamote, Kevin; Delanghe, Sigurd; Speeckaert, Marijn M.; Meerbeeck, Jan P. van; Delanghe, Joris R.

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma 同时靶向VEGFR2和PD-L1促进胸膜间皮瘤的生存和血管正常化

OncoImmunology

IF6.3

2025-05-29

OAAI

Sophie Rovers; Jonas Van Audenaerde; Ruben Verloy; Jorrit De Waele; Louize Brants; Christophe Hermans; Ho Wa Lau; Céline Merlin; Maria Möller Ribas; Peter Ponsaerts; Steven Van Laere; Filip Lardon; An Wouters; Scott A. Fisher; Jan van Meerbeeck; Elly Marcq; Evelien Smits

Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study 基线EORTC QLQ-C30评分对总体生存的预测价值：一项涵盖17种癌症类型的46项临床试验的验证研究

ECLINICALMEDICINE

IF10

2025-04-01

PREAI

Lim, Luigi; Machingura, Abigirl; Taye, Mekdes; Pe, Madeline; Coens, Corneel; Martinelli, Francesca; Alanya, Ahu; Antunes, Stephanie; Tu, Dongsheng; Basch, Ethan; Ringash, Jolie; Brandberg, Yvonne; Groenvold, Mogens; Eggermont, Alexander; Cardoso, Fatima; Van Meerbeeck, Jan; Koller, Michael; van der Graaf, Winette T. A.; Taphoorn, Martin J. B.; Koekkoek, Johan A. F.; Reijneveld, Jaap C.; Soffietti, Riccardo; Velikova, Galina; Bottomley, Andrew; Flechtner, Henning; Musoro, Jammbe

Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases

CLINICAL EPIGENETICS

IF4.4

2024-12-03

OAAI

Vandenhoeck, Janah; Ibrahim, Joe; De Meulenaere, Nele; Peeters, Dieter; Raskin, Jo; Hendriks, Jeroen M. H.; Van Schil, Paul; van Meerbeeck, Jan; Van Camp, Guy; op de Beeck, Ken

Correlating volatile diagnostic biomarkers in exhaled breath to computed tomography imaging in an asbestos-exposed population

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-30

PREAI

Zwijsen, Kathleen; Van Cleemput, Joris; Jonckheere, Caroline; Richart, Tom; Surmont, Veerle; Van Meerbeeck, Jan P.; Janssens, Annelies; Raskin, Jo; Snoeckx, Annemiek; Lamote, Kevin

Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited- Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2024-08-01

OAAI

Walls, Gerard M.; Mistry, Hitesh; Barlesi, Fabrice; Bezjak, Andrea; Le Pechoux, Cecile; O'Brien, Mary; Van Meerbeeck, Jan P.; Blackhall, Fiona; Faivre-Finn, Corinne

A randomised phase II study of extended pleurectomy/ decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-06-06

OAAI

Raskin, Jo; Surmont, Veerle; Maat, Alexander P. W. M.; Yahia, Maha; Burgers, Sjaak A.; Pretzenbacher, Yassin; De Ryck, Frederic; Cornelissen, Robin; Klomp, Houke M.; Oliveira, Ana; Aerts, Joachim; Baas, Paul; Marreaud, Sandrine; Van Meerbeeck, Jan P.; Van Schil, Paul E. Y.

Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B

CELL REPORTS MEDICINE

IF10.6

2023-11-01

OAAI

Le, Xiuning; Paz-Ares, Luis G.; Van Meerbeeck, Jan; Viteri, Santiago; Galvez, Carlos Cabrera; Smit, Egbert F.; Garassino, Marina; Veillon, Remi; Baz, David Vicente; Pradera, Jose Fuentes; Sereno, Maria; Kozuki, Toshiyuki; Kim, Young-Chul; Yoo, Seung Soo; Han, Ji-Youn; Kang, Jin-Hyoung; Son, Choon-Hee; Choi, Yoon Ji; Stroh, Christopher; Juraeva, Dilafruz; Vioix, Helene; Bruns, Rolf; Otto, Gordon; Johne, Andreas; Paik, Paul K.

Determining the clinical utility of a breath test to screen an asbestos-exposed population for pleural mesothelioma.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Zwijsen, Kathleen; Van Cleemput, Joris; Jonckheere, Caroline; Richart, Tom; Nackaerts, Kristiaan; Surmont, Veerle; Van Meerbeeck, Jan P.; Lamote, Kevin

An update regarding the Meso-ORIGINS study: part of the PREDICT-Meso International Accelerator

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Neilly, Mark; Tsim, Selina; Maclay, John; Bilancia, Rocco; Bibby, Anna; Gatheral, Timothy; Ionescu, Alina; Griffiths, Andrew; Aujayeb, Avinash; Rahman, Najib; Fallon, Janet; Craig, Christopher; Macdougall, Michelle; Corcoran, John; Panchal, Rakesh; Chetty, Mahendran; Lamote, Kevin; Cowell, Gordon; Miller, Crispin; Rintoul, Robert; Van Meerbeeck, Jan; Roche, Joshua; Macpherson, Alexandrea; Alexander, Laura; Roberts, Julie; Gourlay, Jacqui; Mcgarry, Joanne; Walker, Nicola; Blyth, Kevin

Exhaled breath analysis predicts treatment response in malignant pleural mesothelioma patients.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Heirwegh, Ellen; Schillebeeckx, Eline; Janssens, Eline; Surmont, Veerle; Nackaerts, Kristiaan; Marcq, Elly; Van Meerbeeck, Jan; Lamote, Kevin

Exhaled breath analysis optimizes nodule management in a lung cancer screening program.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Zwijsen, Kathleen; Wener, Reinier; Janssens, Eline; Schillebeeckx, Eline; Marcq, Elly; Raskin, Jo; Van Meerbeeck, Jan P.; Snoeckx, Annemiek; Janssens, Annelies; Lamote, Kevin

Defining a new diagnostic biomarker panel for malignant pleural mesothelioma using a novel proteomic technique.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-27

PREAI

Schillebeeckx, Eline; Fernandez, Esperanza; Staes, An; Van Meerbeeck, Jan; Gevaert, Kris; Lamote, Kevin

研究方向